Upper respiratory tract mucosal immunity for SARS-CoV-2 vaccines

R Fraser, A Orta-Resendiz, A Mazein… - Trends in molecular …, 2023 - cell.com
SARS-CoV-2 vaccination significantly reduces morbidity and mortality, but has less impact
on viral transmission rates, thus aiding viral evolution, and the longevity of vaccine-induced …

Prospects of animal models and their application in studies on adaptive immunity to SARS-CoV-2

X Wei, N Rong, J Liu - Frontiers in Immunology, 2022 - frontiersin.org
The adaptive immune response induced by SARS-CoV-2 plays a key role in the antiviral
process and can protect the body from the threat of infection for a certain period of time …

Promising Cytokine Adjuvants for Enhancing Tuberculosis Vaccine Immunity

X Cao, YX Fu, H Peng - Vaccines, 2024 - mdpi.com
Tuberculosis, caused by Mycobacterium tuberculosis (M. tuberculosis), remains a
formidable global health challenge, affecting a substantial portion of the world's population …

[HTML][HTML] Glyceraldehyde-3-Phosphate Dehydrogenase Binds with Spike Protein and Inhibits the Entry of SARS-CoV-2 into Host Cells

R Dilawari, GK Chaubey, R Modanwal… - Journal of Innate …, 2024 - karger.com
Introduction: Coronavirus disease 2019 caused by coronavirus-2 (SARS-CoV-2) has
emerged as an aggressive viral pandemic. Health care providers confront a challenging task …

A systematic review and meta-analysis comparing the diagnostic accuracy tests of COVID-19

JJ Vilca-Alosilla, MA Candia-Puma, K Coronel-Monje… - Diagnostics, 2023 - mdpi.com
In this paper, we present a systematic review and meta-analysis that aims to evaluate the
reliability of coronavirus disease diagnostic tests in 2019 (COVID-19). This article seeks to …

[HTML][HTML] Mucosal vaccine development for respiratory viral infections

Y Lin, Z Hu, YX Fu, H Peng - hLife, 2023 - Elsevier
Mucosal vaccines have risen to prominence in the corona virus disease 2019 (COVID-19)
pandemic due to their ability to elicit both local antibody and tissue-resident T-cell …